🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In a large prospective study, long-term aspirin use was associated with the greatest reduction in risk of colorectal cancer among those with unhealthier lifestyles compared to those with healthier lifestyles. ja.ma/48lMyhD

Another GLP-1 success, semaglutide for relief of knee osteoarthritis in people with obesity, a randomized trial NEJM nejm.org/doi/full/10.10…

Most viewed from JAMA Surgery: Although it is known that female pts die more often than male patients after high-risk surgery, is this because female pts have more complications or because clinicians fail to rescue female pts from those complications? ja.ma/3YAruke

In the STEP 9 trial, researchers evaluated whether the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide is superior to placebo in reducing body weight and pain related to knee osteoarthritis in persons with obesity and knee osteoarthritis. nej.md/40oSLHB

If you teach epidemiology, public health, or statistics, this is your official notice that "Hill's Criteria" is now called "Hill's List of Standards". Just like Sir Austin Bradford Hill always intended. #EpiAnIntro #UpdateYourSlides

Most viewed in the last 7 days from JAMA Oncology: In a study of over 4,500 cancer patients, those who quit smoking within 6 months of diagnosis through a cessation program showed the greatest survival benefit. ja.ma/3UISQT2

Registration for the AACR Annual Meeting 2025 (April 25-30; Chicago) is now open. Register by January 3 to get the lowest rates for #AACR25. Learn more: bit.ly/3O7MMQg

Thanks WashU Medicine for finding this in my mailbox! Read more about cancer research and care breakthroughs happening in WashU and Siteman Cancer Center in the latest Outlook edition. outlook.washu.edu/?utm_source=Em…

New in The Lancet Oncology, led by American Cancer Society and including PROSPECT co-team lead Yin Cao ⤵️ An important update on #ColorectalCancer rates and trends in younger versus older age groups globally. thelancet.com/journals/lanon…

With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers. Cancer Today outlines how it's making a difference for patients: bit.ly/49S5168

Quitting smoking within 6 months of a cancer diagnosis improves survival outcomes, with the greatest benefits observed in those who enter cessation programs promptly. ja.ma/4iTDsxr

“St. Louis is not just our address — it’s our home." In 2024, WashU’s impact on the St. Louis economy reached $9.3 billion, supporting thousands of jobs, groundbreaking research, and community-driven initiatives #InSTLforSTL. bit.ly/4hAaEsB

Excited to be seeing the global #CancerResearch community at #AACR25 this week! 🌎 Drop by booth 2327 to meet our team, learn about our 7 new #CancerGrandChallenges (more on those here: bit.ly/4iOry7A), and how to apply for funding to take them on. See you there 👋

📣 Calling all colleagues & friends attending AACR25 — researchers, clinicians & advocates! 🔬 Join our team “RACE: Research Against Cancers of Early-Onset” at the AACR Runners for Research 5K Run/Walk on Saturday, April 26 in Chicago. AACR Foundation

Great run/walk/freezing in Chicago lakeside! Happy to take part in this event held by #AACR25 to support cancer research!

If you are interested in the epidemiology of risk factors driving early-onset cancers and attending #AACR2025, please stop by my poster in section 42 on Wednesday April 30. #AACR25 #PROSPECT

Early-onset colorectal cancer clinical challenges. A great talk by Cassandra Fritz, MD, MPHS at #AACR2025! #AACR25 #EOCRC

#AACR25: Great to see Yin Cao's lab (Yin Cao) support WashU Medicine gastroenterologist Dr. Fritz (@CFritzMD) during her AACR abstract presentation this morning entitled, 'Early detection and prevention of early-onset colorectal cancer: Clinical challenges and the paths

Great opportunity to advance my knowledge and skills in molecular cancer epidemiology at the #AACR IME Workshop! Learned from top faculty and connected with brilliant researchers. Highly recommend!